- Home
- GNSS vs VSTM Comparison
GNSS vs VSTM Comparison
Compare GNSS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- VSTM
- Stock Information
- Founded
- GNSS 1992
- VSTM 2010
- Country
- GNSS United States
- VSTM United States
- Employees
- GNSS N/A
- VSTM N/A
- Industry
- GNSS Consumer Electronics/Appliances
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- VSTM Health Care
- Exchange
- GNSS Nasdaq
- VSTM Nasdaq
- Market Cap
- GNSS 169.5M
- VSTM 132.0M
- IPO Year
- GNSS N/A
- VSTM 2012
- Fundamental
- Price
- GNSS $3.75
- VSTM $3.88
- Analyst Decision
- GNSS Strong Buy
- VSTM Strong Buy
- Analyst Count
- GNSS 3
- VSTM 8
- Target Price
- GNSS $5.08
- VSTM $14.57
- AVG Volume (30 Days)
- GNSS 106.7K
- VSTM 1.1M
- Earning Date
- GNSS 12-05-2024
- VSTM 11-06-2024
- Dividend Yield
- GNSS N/A
- VSTM N/A
- EPS Growth
- GNSS N/A
- VSTM N/A
- EPS
- GNSS N/A
- VSTM N/A
- Revenue
- GNSS $27,968,000.00
- VSTM $10,000,000.00
- Revenue This Year
- GNSS N/A
- VSTM N/A
- Revenue Next Year
- GNSS $138.10
- VSTM $125.69
- P/E Ratio
- GNSS N/A
- VSTM N/A
- Revenue Growth
- GNSS N/A
- VSTM N/A
- 52 Week Low
- GNSS $1.51
- VSTM $2.10
- 52 Week High
- GNSS $4.04
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- GNSS 60.29
- VSTM 63.77
- Support Level
- GNSS $3.67
- VSTM $3.11
- Resistance Level
- GNSS $3.94
- VSTM $3.76
- Average True Range (ATR)
- GNSS 0.14
- VSTM 0.33
- MACD
- GNSS -0.02
- VSTM 0.04
- Stochastic Oscillator
- GNSS 77.78
- VSTM 94.26
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.